Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pediatric erythroblastic transformation of JAK2-mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations.

Pediatric blood & cancer - 1 Oct 2023

Oshiro Tokiko, Hamada Satoru, Kiyuna Sinobu, Sakiyama Hideki, Hyakuna Nobuyuki, Tamaki Tomoko, Muramatsu Hideki, Nakanishi Koichi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Bone Marrow
Share to Calreticulin
Share to Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Primary Myelofibrosis

Share to Repressor Proteins

Source

Identifiers

PMID: 37337098
DOI: 10.1002/pbc.30508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pediatric erythroblastic transformation of JAK2-mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations.PMID 37337098Read ↗

Myelofibrosis biology and contemporary management.Semantic proximity Read ↗

NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?Semantic proximity Read ↗

A rare de novo pure erythroid leukemia with JAK2 R683S mutation.Semantic proximity Read ↗

Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.Semantic proximity Read ↗

Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort.Semantic proximity Read ↗

PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemiaSemantic proximity Read ↗

After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera.Semantic proximity Read ↗

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2Semantic proximity Read ↗

Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.Semantic proximity Read ↗

Novel therapies for myelofibrosis.Semantic proximity Read ↗

An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation.Semantic proximity Read ↗

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.